This inventor holds 2 USPTO granted patents. Top assignees: Pliva and Pliva Handels Gmbh, Pliva, Farmaceutska, Kemijska, Prehrambena I Kozmeticka Industrija,. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gajnice, HR (1995)
- Zagreb, HR (1995)
Company Filing History:
Years Active: 1995
Title: Zinka Brkic: Innovator in Pharmaceutical Chemistry
Introduction
Zinka Brkic is a notable inventor based in Gajnice, Croatia. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative patents. With a total of 2 patents, her work has had a meaningful impact on the development of new chemical compounds.
Latest Patents
Zinka's latest patents include "Amides of 4-oxo-azetidine-2-sulfonic acids and salts thereof." This invention relates to novel 4-oxo-azetidine-2-sulfonic acid amides and their salts, which have various applications in medicinal chemistry. Another significant patent is for "5-thia-1,4-diazabicyclo[4.2.0]octane-3,8-dioxo analogs of β-lactam." This patent discloses new analogs of β-lactam that are crucial for developing antibiotics and other therapeutic agents.
Career Highlights
Throughout her career, Zinka has worked with several prominent companies in the pharmaceutical industry. She has been associated with Pliva, a leading pharmaceutical company, as well as Farmaceutska, Kemijska, and Prehrambena i Kozmetička Industrija. Additionally, she has worked with Pliva Handels GmbH, further enhancing her expertise in the field.
Collaborations
Zinka has collaborated with notable colleagues, including Jure J. Herak and Mice Kovacevic. These partnerships have contributed to her innovative research and development efforts in pharmaceutical chemistry.
Conclusion
Zinka Brkic is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. Her patents reflect her commitment to innovation and her contributions to the development of new therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile